European Commission gives nod to Novartis’ novel therapy to treat breast cancer
- Posted on November 27, 2024
- By Financial Express
- 2 Views
European Commission gives nod to Novartis’ novel therapy to treat breast cancer
Following recent data announcements at ESMO 20246, Novartis will continue to evaluate NATALEE patients for longer-term outcomes, including overall survival, the company stated.
